UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) ~~of the Securities Exchange Act of 1934~~

~~Date~~ of ~~Report~~the ~~(date~~Securities ofExchange ~~earliest~~Act ~~event~~of ~~reported): May~~1934 ~~7, 2018 (May 7, 2018)~~

~~Monsanto~~Date ~~Company~~of Report (~~Exact~~Date ~~name~~ of ~~registrant~~earliest asevent ~~specified~~reported): inJune 7, ~~its~~2018 ~~charter)~~

Delaware	001-16167	43-1878297
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

Monsanto Company

~~800 North Lindbergh Boulevard St. Louis, Missouri 63167~~ (~~Address~~Exact Name of ~~principal executive offices and zip code)~~ Registrant’s ~~telephone~~as ~~number,~~Specified ~~including~~in ~~area~~its ~~code: (314~~Charter) ~~694-1000~~

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

Delaware

001-16167

43-1878297

(State of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

800 North Lindbergh Blvd.

St. Louis, Missouri 63167

(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code: (314) 694-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under ~~The~~the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under ~~The~~the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 58.~~02. Departure~~01 ofOther ~~Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Events.

AsOn ~~previously~~June 7, ~~disclosed~~2018, Monsanto Company (~~the "Company"~~“Monsanto”) isissued ~~party~~a topress arelease ~~merger~~announcing ~~agreement~~the ~~providing~~completion ~~for~~of the ~~acquisition~~merger of ~~the~~KWA ~~Company~~Investment byCo. (“Merger Sub”) with and into Monsanto, with Monsanto continuing as an indirect, wholly-owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation ("“Bayer"”), onpursuant to the ~~terms~~Agreement and ~~conditions~~Plan ~~contained~~of ~~therein. The~~Merger, ~~completion~~dated as of September 14, ~~the~~2016, ~~merger~~by ~~remains~~and ~~subject~~among toBayer, ~~satisfaction~~Merger Sub and Monsanto. A copy of ~~certain~~the ~~closing~~press ~~conditions,~~release ~~including~~is ~~receipt~~attached ofhereto ~~required~~as ~~regulatory~~Exhibit ~~approvals~~99.1 and is incorporated by reference herein.

OnItem ~~May 7, 2018, the Company's Chairman and Chief Executive Officer announced that he will be departing the Company at the closing of the merger~~9. In01 ~~addition, on May 7, 2018, the Company's Senior Vice President and Chief~~ Financial ~~Officer,~~Statements ~~the Company's Executive Vice President~~ and ~~Chief Technology Officer and the Company's Executive Vice President, Secretary and General Counsel announced that they will be departing the Company shortly after the closing of the merger~~Exhibits. Current executives of the Company who will transition to become members of the Crop Science Executive Leadership Team at Bayer once the merger is closed include the Company's President and Chief Operating Officer.

~~All~~(d) ~~of the foregoing officers are expected to continue in their current roles through the completion of the merger.~~Exhibits

Item 7.01. Regulation FD Disclosure


Exhibit No.		Description of Exhibit

99.1		Press Release, dated June 7, 2018

OnEXHIBIT ~~May~~INDEX ~~7, 2018, the Company issued a press release regarding certain of the matters described in Item 5.02, which press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.~~

Item 9.01. Financial Statements and Exhibits.


Exhibit No.		Description of Exhibit

99.1		Press Release, dated June 7, 2018

~~(d)~~SIGNATURES ~~Exhibits~~

Exhibit	Description of Document
99.1	Press Release of Monsanto Company, issued May 7, 2018.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

SIGNATURE


		MONSANTO COMPANY

Date: June 7, 2018	By:	/s/ Michelle Bushore
		Name:	Michelle Bushore
		Title:	Corporate Secretary

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MONSANTO COMPANY
Date: May 7, 2018	By:	/s/ Michelle Bushore
		Name: Michelle Bushore
		Title: Deputy General Counsel and Chief Legal Officer, Climate

Filing Compare · MONSANTO CO /NEW/